Diplomat Pharmacy (DPLO) Tops Q1 EPS by 1c; Boosts FY15 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Diplomat Pharmacy (DPLO) Tops Q1 EPS by 1c; Boosts FY15 Outlook

Diplomat Announces 1st Quarter Financial Results

May 11, 2015 4:07 PM EDT

FLINT, Mich., May 11, 2015 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced financial results for the quarter ended March 31, 2015. All comparisons, unless otherwise noted, are to the quarter ended March 31, 2014.

First Quarter 2015 Highlights include:

Revenue of $625 million, an increase of 34% Total prescriptions dispensed of 194,000, an increase of 6% Gross margin of 6.6% versus 6.3% Adjusted EBITDA of $11.2 million, an increase of 36% Adjusted EPS of $0.09, versus $0.05... More